His primary areas of study are Virology, Antibody, Epitope, Neutralization and Protein structure. Yongping Yang has researched Virology in several fields, including Affinity maturation and Glycoprotein. Yongping Yang combines subjects such as Molecular biology and Glycosylation with his study of Antibody.
The Glycosylation study combines topics in areas such as Peptide sequence and Glycan. His work carried out in the field of Epitope brings together such families of science as Motavizumab and Viral protein. His biological study spans a wide range of topics, including Lipid bilayer fusion and Gp41.
Yongping Yang mostly deals with Virology, Antibody, Epitope, Neutralization and Protein structure. His Virology study combines topics in areas such as Glycoprotein, Immune system and Antigen. His Antibody research includes themes of Molecular biology, Bioinformatics, Binding site and Glycan.
His Epitope research is multidisciplinary, relying on both Viral entry, Motavizumab, Somatic hypermutation and Peptide sequence. His Neutralization research focuses on subjects like Complementarity determining region, which are linked to Affinity maturation. His Protein structure research integrates issues from Plasma protein binding and Gp41.
Yongping Yang spends much of his time researching Virology, Antibody, Neutralization, Trimer and Neutralizing antibody. His Human Parainfluenza Virus study in the realm of Virology interacts with subjects such as Ectodomain. His research is interdisciplinary, bridging the disciplines of Vaccination and Antibody.
The study incorporates disciplines such as Epitope, Heterologous and Immunization in addition to Neutralization. Yongping Yang has included themes like Hemagglutinin, Biochemistry, Ferritin and Glycan in his Neutralizing antibody study. His Virus research incorporates elements of Immunogen and Glycoprotein.
Yongping Yang mainly focuses on Antibody, Neutralization, Virology, Neutralizing antibody and Epitope. His Antibody research includes themes of Virus and Glycan. His work deals with themes such as Immunogen and Glycoprotein, which intersect with Virus.
His Glycan study combines topics from a wide range of disciplines, such as Mutation, Protein subunit and Somatic hypermutation. His research in Monoclonal antibody intersects with topics in Viral entry, Viral protein and Peptide sequence. Other disciplines of study, such as Ferritin, Antigen, Immunogenicity, Biochemistry and Hemagglutinin, are mixed together with his Monomer studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang.
Science (2010)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman.
Nature (2011)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder.
Nature (2012)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore.
Nature (2014)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev.
Nature (2014)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry.
Science (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan;Man Chen;Sherman Leung;Kevin W. Graepel.
Science (2013)
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
Jason S. McLellan;Yongping Yang;Barney S. Graham;Peter D. Kwong.
Journal of Virology (2011)
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G
Guillaume B.E. Stewart-Jones;Cinque Soto;Thomas Lemmin;Thomas Lemmin;Gwo Yu Chuang.
Cell (2016)
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
Marie Pancera;Syed Shahzad-Ul-Hussan;Nicole A. Doria-Rose;Jason S. McLellan.
Nature Structural & Molecular Biology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
National Institutes of Health
Vanderbilt University Medical Center
National Institutes of Health
Moderna Therapeutics (United States)
Fred Hutchinson Cancer Research Center
National Institutes of Health
Columbia University
Henry M. Jackson Foundation
Northwestern Polytechnical University
Argonne National Laboratory
Nokia (United States)
Jilin University
University of Castilla-La Mancha
Lund University
Durham University
Kyoto University
Chinese Academy of Sciences
University of Maryland, College Park
University of Tübingen
Temple University
Sanford Burnham Prebys Medical Discovery Institute
Fred Hutchinson Cancer Research Center
University of Western Australia
University of Warwick